Drug Shortage Report for PACLITAXEL INJECTION USP

Last updated on 2017-08-02 History
Report ID 15457
Drug Identification Number 02320150
Brand name PACLITAXEL INJECTION USP
Common or Proper name PACLITAXEL
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) PACLITAXEL
Strength(s) 6MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 50ML VIAL
ATC code L01CD
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2017-07-19
Actual start date
Estimated end date 2017-07-31
Actual end date 2017-07-28
Shortage status Resolved
Updated date 2017-08-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2017-08-02 French Compare
v7 2017-08-02 English Compare
v6 2017-07-20 English Compare
v5 2017-07-18 French Compare
v4 2017-07-18 English Compare
v3 2017-07-12 English Compare
v2 2017-07-11 French Compare
v1 2017-07-11 English Compare

Showing 1 to 8 of 8